hexamethonium has been researched along with Schizophrenia in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KUTSENOK, BM | 1 |
| PELIPAS, VE | 1 |
| KOVALEV, VV | 1 |
| KAZANSKAIA, AE | 1 |
2 other studies available for hexamethonium and Schizophrenia
| Article | Year |
|---|---|
[SOME RESULTS OF THE USE OF HEXONIUM IN INSULIN THERAPY OF SCHIZOPHRENIA WITH PROLONGED COURSE].
Topics: Adolescent; Convulsive Therapy; Drug Therapy; Hexamethonium; Hexamethonium Compounds; Humans; Insuli | 1965 |
[Experience in treatment with shock doses of insulin in combination with hexonium in schizophrenia].
Topics: Autonomic Agents; Autonomic Nervous System; Convulsive Therapy; Hexamethonium; Hexamethonium Compoun | 1962 |